Kevin Du
MD, PhD, MSCI
Associate Professor of Therapeutic Radiology; Medical Director, Radiation Oncology Center, Smilow Cancer Hospital in Trumbull; Network Outreach, Therapeutic Radiology
Research & Publications
Biography
News
Coauthors
Selected Publications
- Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.Tchelebi L, Winter K, Abrams RA, Safran H, Regine WF, McNulty S, Wu AJ, Du KL, Seaward SA, Bian SX, Aljumaily R, Shivnani AT, Moore T, Crocenzi T, DiPetrillo TA, Kuykendal A, Crane CH, Goodman KA. Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848. International Journal Of Radiation Oncology, Biology, Physics 2021, 111: S40. PMID: 34700550, DOI: 10.1016/j.ijrobp.2021.07.114.
- Interprofessional Image Verification Workshop for Physician and Physics Residents: A Multi-Institutional ExperiencePadilla L, Burmeister JW, Burnett OL, Covington EL, Den RB, Dominello MM, Du KL, Galavis PE, Junell S, Kahn J, Kishore M, Mooney K, Mukhopadhyay ND, Studenski MT, Yechieli RL, Fields EC. Interprofessional Image Verification Workshop for Physician and Physics Residents: A Multi-Institutional Experience. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: 1058-1065. PMID: 34380009, DOI: 10.1016/j.ijrobp.2021.07.1706.
- Breaking Tradition to Bridge Bench and Bedside: Accelerating the MD-PhD-Residency Pathway.Modrek AS, Tanese N, Placantonakis DG, Sulman EP, Rivera R, Du KL, Gerber NK, David G, Chesler M, Philips MR, Cangiarella J. Breaking Tradition to Bridge Bench and Bedside: Accelerating the MD-PhD-Residency Pathway. Academic Medicine 2021, 96: 518-521. PMID: 33464738, DOI: 10.1097/acm.0000000000003920.
- A Single Institution Review Of Efficacy Of Neoadjuvant Chemoradiation With Gemcitabine/Abraxane Compared to FOLFIRINOX in Pancreatic Ductal AdenocarcinomaNguy S, Du K. A Single Institution Review Of Efficacy Of Neoadjuvant Chemoradiation With Gemcitabine/Abraxane Compared to FOLFIRINOX in Pancreatic Ductal Adenocarcinoma. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e658-e659. DOI: 10.1016/j.ijrobp.2020.07.1972.
- Interprofessional Image Verification Workshop for Physician and Physics Residents: A Multi-Institutional ExperiencePadilla L, Burmeister J, Burnett O, Covington E, Den R, Dominello M, Du K, Galavis P, Junell S, Kahn J, Kishore M, Mooney K, Studenski M, Yechieli R, Fields E. Interprofessional Image Verification Workshop for Physician and Physics Residents: A Multi-Institutional Experience. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e433. DOI: 10.1016/j.ijrobp.2020.07.2517.
- Effects of M-CSF Inhibition And Radiotherapy In A Murine Model Of Colorectal CancerNguy S, Diskin B, Adam S, Li E, Liria M, Domogauer J, Taneja S, Teruel J, Wang H, Osterman S, Miller G, Du K. Effects of M-CSF Inhibition And Radiotherapy In A Murine Model Of Colorectal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e543-e544. DOI: 10.1016/j.ijrobp.2020.07.1694.
- A phase I/II multisite study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC).Wu J, Atkinson E, Leichman L, Patel H, Iqbal S, Du K, Bizekis C, Goldberg J, Thomas C, Cohen D, Becker D, Siolas D, Beri N, Oberstein P, Ku G. A phase I/II multisite study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). Journal Of Clinical Oncology 2020, 38: 372-372. DOI: 10.1200/jco.2020.38.4_suppl.372.
- Phase II multi-institutional study of nivolumab (Nivo), cabiralizumab (Cabira), and stereotactic body radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer (LAUPC).Cohen D, Medina B, Du K, Coveler A, Manji G, Oberstein P, Perna S, Miller G. Phase II multi-institutional study of nivolumab (Nivo), cabiralizumab (Cabira), and stereotactic body radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer (LAUPC). Journal Of Clinical Oncology 2019, 37: tps4163-tps4163. DOI: 10.1200/jco.2019.37.15_suppl.tps4163.
- Survival Outcomes and Prognostic Factors for Gastric Cancer in the Adjuvant Setting: An Analysis of the National Cancer DatabaseNguy S, Wu P, Lee A, Tam M, Schreiber D, Du K. Survival Outcomes and Prognostic Factors for Gastric Cancer in the Adjuvant Setting: An Analysis of the National Cancer Database. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e49. DOI: 10.1016/j.ijrobp.2018.07.462.
- Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysisChadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, Maas M, Bitterman DS, Du K, Gollins S, Myint A, Smith FM, Saunders MP, Scott N, O'Dwyer ST, de Castro Araujo RO, Valadao M, Lopes A, Hsiao CW, Lai CL, Smith RK, Paulson EC, Appelt A, Jakobsen A, Wexner SD, Habr-Gama A, Julião G, Perez R, Renehan AG. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. The Lancet Gastroenterology & Hepatology 2018, 3: 825-836. PMID: 30318451, DOI: 10.1016/s2468-1253(18)30301-7.
- Initial experience of combination nivolumab and local-regional treatment in patients with advanced hepatocellular carcinoma (HCC).Gu P, Park J, Zhong J, Guo S, Hickey R, Aaltonen E, Horn J, Du K, Shanbhogue K, Megibow A, Xu R, Kyritsis I, Cohen D, Newman E, Miller G, Welling T. Initial experience of combination nivolumab and local-regional treatment in patients with advanced hepatocellular carcinoma (HCC). Journal Of Clinical Oncology 2018, 36: e16149-e16149. DOI: 10.1200/jco.2018.36.15_suppl.e16149.
- A phase I/II multi-center study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC).Giuroiu I, Ku G, Leichman L, Du K, Oh P, Levinson B, Iqbal S, Thomas C, Wu J. A phase I/II multi-center study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC). Journal Of Clinical Oncology 2018, 36: tps199-tps199. DOI: 10.1200/jco.2018.36.4_suppl.tps199.
- Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancerWang H, Du K, Qu J, Chandarana H, Das IJ. Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer. PLOS ONE 2018, 13: e0190883. PMID: 29304105, PMCID: PMC5755922, DOI: 10.1371/journal.pone.0190883.
- Patient Positioning Accuracy in Stereotactic Radiosurgery With Mask Fixation and Cone Beam CTXu Y, Silverman J, Du K, Das I, Kondziolka D. Patient Positioning Accuracy in Stereotactic Radiosurgery With Mask Fixation and Cone Beam CT. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e740-e741. DOI: 10.1016/j.ijrobp.2017.06.2383.
- Development and Implementation of a Statistics Curriculum for Radiation Oncology ResidentsGorovets D, Wu P, Ahmed I, Cohen P, Ishaq O, Katz L, Oh P, Shaikh F, Tam M, Rawn E, Du K, Vega R. Development and Implementation of a Statistics Curriculum for Radiation Oncology Residents. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e124. DOI: 10.1016/j.ijrobp.2017.06.893.
- Biomarkers that Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal CancerOh P, Du K. Biomarkers that Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. Current Colorectal Cancer Reports 2017, 13: 276-283. DOI: 10.1007/s11888-017-0376-3.
- Food as medicine: A randomized controlled trial (RCT) of home delivered, medically tailored meals (HDMTM) on quality of life (QoL) in metastatic lung and non-colorectal GI cancer patients.Ishaq O, Mailhot Vega R, Zullig L, Wassung A, Walters D, Berland N, Du K, Ahn J, Leichman C, Jill Cohen D, Gu P, Chachoua A, Leichman L, Pearl K, Schiff P. Food as medicine: A randomized controlled trial (RCT) of home delivered, medically tailored meals (HDMTM) on quality of life (QoL) in metastatic lung and non-colorectal GI cancer patients. Journal Of Clinical Oncology 2016, 34: 155-155. DOI: 10.1200/jco.2016.34.26_suppl.155.
- PD-1 Blockade Enhances the Efficacy of Chemoradiation in a Mouse Model of Esophageal CancerOh P, Du K, Leichman L, Aifantis I. PD-1 Blockade Enhances the Efficacy of Chemoradiation in a Mouse Model of Esophageal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s127-s128. DOI: 10.1016/j.ijrobp.2016.06.311.
- Influence of Neutrophil-Lymphocyte Ratio and Other Independent Factors Predicting Failure in Locally Advanced Esophageal MalignanciesMathew M, Elahi N, Osipov A, Bitterman D, Talcott W, Tuli R, Du K, Thomas T. Influence of Neutrophil-Lymphocyte Ratio and Other Independent Factors Predicting Failure in Locally Advanced Esophageal Malignancies. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e204. DOI: 10.1016/j.ijrobp.2016.06.1104.
- Updated Analysis of a Multi-Institutional Radiation Oncology Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study GroupKauffmann G, Gunther J, Braunstein S, Hara W, Spektor A, Brower J, Stahl J, Rao Y, Vargo J, Ye J, Fields E, Thomas C, Du K, Kruser T, Jimenez R, Hirsch A, Currey A, Yechieli R, Mohindra P, Golden D. Updated Analysis of a Multi-Institutional Radiation Oncology Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e412. DOI: 10.1016/j.ijrobp.2016.06.1666.
- Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in MiceSeifert L, Werba G, Tiwari S, Ly N, Nguy S, Alothman S, Alqunaibit D, Avanzi A, Daley D, Barilla R, Tippens D, Torres-Hernandez A, Hundeyin M, Mani VR, Hajdu C, Pellicciotta I, Oh P, Du K, Miller G. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology 2016, 150: 1659-1672.e5. PMID: 26946344, PMCID: PMC4909514, DOI: 10.1053/j.gastro.2016.02.070.
- Methylation profiling of locally advanced rectal cancer (LARC): Exploration of potential predictive markers for neoadjuvant chemoradiation (NACR).Guo S, Melamed J, Eze O, Bowman C, Ahmed S, Moore H, Loomis C, Heguy A, Brody R, Morrison D, Serrano J, Du K, Wu J, Ryan T, Cohen D, Gu P, Goldberg J, Snuderl M, Leichman L, Leichman C. Methylation profiling of locally advanced rectal cancer (LARC): Exploration of potential predictive markers for neoadjuvant chemoradiation (NACR). Journal Of Clinical Oncology 2016, 34: 614-614. DOI: 10.1200/jco.2016.34.4_suppl.614.
- Abstract A145: Radiation therapy induces tumor-promoting immune suppression in the microenvironment of pancreatic carcinomaTomkötter L, Werba G, Nguy S, Alothman S, Alqunaibit D, Tiwari S, Ly N, Daley D, Ochi A, Barilla R, Torres-Hernandez A, Pellicciotta I, Du K, Miller G. Abstract A145: Radiation therapy induces tumor-promoting immune suppression in the microenvironment of pancreatic carcinoma. Cancer Immunology Research 2016, 4: a145-a145. DOI: 10.1158/2326-6074.cricimteatiaacr15-a145.
- Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal CancerBitterman DS, Salgado L, Moore HG, Sanfilippo NJ, Gu P, Hatzaras I, Du KL. Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer. Frontiers In Oncology 2015, 5: 286. PMID: 26734570, PMCID: PMC4686647, DOI: 10.3389/fonc.2015.00286.
- HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy EraGrew D, Bitterman D, Leichman CG, Leichman L, Sanfilippo N, Moore HG, Du K. HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era. Diseases Of The Colon & Rectum 2015, 58: 1130-1136. PMID: 26544809, DOI: 10.1097/dcr.0000000000000476.
- Role of the Resident as a Teacher (RAT) in the Medical Student (MS) Clerkship: A Report From the Radiation Oncology Education Collaborative Study GroupBraunstein S, Gunther J, Spektor A, Falit B, Mirabeau-Beale K, Young K, Brower J, Mancini B, Ye J, Rajagopalan M, Du K, Rao Y, Hara W, Currey A, Jimenez R, Golden D. Role of the Resident as a Teacher (RAT) in the Medical Student (MS) Clerkship: A Report From the Radiation Oncology Education Collaborative Study Group. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e379. DOI: 10.1016/j.ijrobp.2015.07.1514.
- Predictors of Complete Response and Recurrence Following Neoadjuvant Chemoradiation Therapy in Rectal CancerBitterman D, Resende-Salgado L, Moore H, Sanfilippo N, Gu P, Hatzaras I, Du K. Predictors of Complete Response and Recurrence Following Neoadjuvant Chemoradiation Therapy in Rectal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e145-e146. DOI: 10.1016/j.ijrobp.2015.07.919.
- Effect of Resident Involvement on Improving Pain Management in a Radiation Oncology Department: A Multidisciplinary Microsystems Approach Focusing on Patient Reported OutcomesCooper B, Smith B, Oliveri M, Brown J, Cabrera A, Gumbs K, Sanfilippo N, Du K. Effect of Resident Involvement on Improving Pain Management in a Radiation Oncology Department: A Multidisciplinary Microsystems Approach Focusing on Patient Reported Outcomes. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e487-e488. DOI: 10.1016/j.ijrobp.2015.07.1792.
- Evaluation of a Multi-institutional Radiation Oncology Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study GroupGolden D, Spektor A, Gunther J, Thaker N, Braunstein S, Young K, Bornstein S, Hung A, Brower J, Mohindra P, Mancini B, Ye J, Rajagopalan M, Du K, Rao Y, Gibbs I, Hara W, Kharofa J, Currey A, Jimenez R. Evaluation of a Multi-institutional Radiation Oncology Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e376. DOI: 10.1016/j.ijrobp.2015.07.1506.
- Dosimetric Comparison of Proton Therapy, Volumetric Modulated Arc Therapy, and 3-D Conformal Radiation Therapy for the Treatment of Rectal Cancer: An Early Community ExperienceCooper B, Qu J, Chon B, Tsai H, Mah D, Du K, DeWyngaert J, Yeh B. Dosimetric Comparison of Proton Therapy, Volumetric Modulated Arc Therapy, and 3-D Conformal Radiation Therapy for the Treatment of Rectal Cancer: An Early Community Experience. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e176. DOI: 10.1016/j.ijrobp.2015.07.999.
- Anal Cancer Outcomes in Patients Treated With Intensity Modulated Compared to 3-Dimensional Radiation TherapyCooper B, Bitterman D, Grew D, No H, Sanfilippo N, Du K. Anal Cancer Outcomes in Patients Treated With Intensity Modulated Compared to 3-Dimensional Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e165. DOI: 10.1016/j.ijrobp.2015.07.972.
- Radiation Therapy Induces an Immunosuppressive Immune Infiltrate in a Murine Model of Invasive Pancreatic CancerNguy S, Tomkoetter L, Alothman S, Alqunaibit D, Miller G, Du K. Radiation Therapy Induces an Immunosuppressive Immune Infiltrate in a Murine Model of Invasive Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s95-s96. DOI: 10.1016/j.ijrobp.2015.07.229.
- Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center.Bitterman DS, Grew D, Gu P, Cohen RF, Sanfilippo NJ, Leichman CG, Leichman LP, Moore HG, Gold HT, Du KL. Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center. Journal Of Gastrointestinal Oncology 2015, 6: 524-33. PMID: 26487947, PMCID: PMC4570920, DOI: 10.3978/j.issn.2078-6891.2015.061.
- Medical Student Perspectives on a Multi-institutional Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study GroupYe JC, Mohindra P, Spektor A, Krishnan MS, Chmura SJ, Howard AR, Viswanathan AN, MacDonald SM, Thaker NG, Das P, Mancini BR, Higgins SA, Braunstein S, Haas-Kogan D, Bradley KA, Hung AY, Thomas CR, Kharofa J, Wheatley M, Currey A, Parashar B, Du K, Jimenez RB, Golden DW. Medical Student Perspectives on a Multi-institutional Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group. International Journal Of Radiation Oncology • Biology • Physics 2015, 92: 217-219. PMID: 25968822, PMCID: PMC4768460, DOI: 10.1016/j.ijrobp.2015.01.043.
- Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) dataModrek AS, Hsu HC, Leichman CG, Du KL. Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data. Radiation Oncology 2015, 10: 101. PMID: 25902707, PMCID: PMC4464878, DOI: 10.1186/s13014-015-0411-y.
- Anal cancer outcomes in patients treated with intensity modulated versus 3-dimensional chemoradiotherapy.Cooper B, Grew D, Bitterman D, Sanfilippo N, Du K. Anal cancer outcomes in patients treated with intensity modulated versus 3-dimensional chemoradiotherapy. Journal Of Clinical Oncology 2015, 33: 662-662. DOI: 10.1200/jco.2015.33.3_suppl.662.
- Outcomes of rectal cancer with liver oligometastases.Resende Salgado L, Hsu H, Du K. Outcomes of rectal cancer with liver oligometastases. Journal Of Gastrointestinal Oncology 2014, 5: 414-20. PMID: 25436119, PMCID: PMC4226821, DOI: 10.3978/j.issn.2078-6891.2014.078.
- Outcomes of Oligometastatic Rectal Cancer Treated With Extended Course Pelvic IrradiationSalgado L, Hsu H, Du K. Outcomes of Oligometastatic Rectal Cancer Treated With Extended Course Pelvic Irradiation. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s391. DOI: 10.1016/j.ijrobp.2014.05.1252.
- Disparities in the Treatment and Outcome of Anal Cancer in Public and Private Hospital PatientsBitterman D, Grew D, Leichman C, Leichman L, Du K. Disparities in the Treatment and Outcome of Anal Cancer in Public and Private Hospital Patients. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s33-s34. DOI: 10.1016/j.ijrobp.2014.05.143.
- Significantly Worse Colostomy-Free Survival in Human Immunodeficiency Virus–Positive Patients After Definitive Chemoradiation for Anal CancerGrew D, Bitterman D, Leichman C, Leichman L, Du K. Significantly Worse Colostomy-Free Survival in Human Immunodeficiency Virus–Positive Patients After Definitive Chemoradiation for Anal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s398-s399. DOI: 10.1016/j.ijrobp.2014.05.1273.
- Implementation and Evaluation of a Multi-institutional Radiation Oncology Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study GroupGolden D, Spektor A, Krishnan M, Thaker N, Mancini B, Braunstein S, Mohindra P, Hung A, Kharofa J, Ye J, Du K, Jimenez R. Implementation and Evaluation of a Multi-institutional Radiation Oncology Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s600. DOI: 10.1016/j.ijrobp.2014.05.1798.
- Chemoradiation Therapy versus Chemotherapy Alone for Gastric Cancer after R0 Surgical Resection: A Meta-Analysis of Randomized TrialsMin C, Bangalore S, Jhawar S, Guo Y, Nicholson J, Formenti SC, Leichman LP, Du KL. Chemoradiation Therapy versus Chemotherapy Alone for Gastric Cancer after R0 Surgical Resection: A Meta-Analysis of Randomized Trials. Oncology 2014, 86: 79-85. PMID: 24435019, DOI: 10.1159/000354641.
- Radiation Therapy Improves Survival in Small Cell Rectal Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) DataHsu H, Leichman C, Du K. Radiation Therapy Improves Survival in Small Cell Rectal Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s188. DOI: 10.1016/j.ijrobp.2013.06.484.
- Chemoradiation Therapy Versus Chemotherapy Alone for Gastric Cancer After R0 Surgical Resection: A Meta-Analysis of Randomized TrialsMin C, Bangalore S, Jhawar S, Guo Y, Nicholson J, Formenti S, Leichman L, Du K. Chemoradiation Therapy Versus Chemotherapy Alone for Gastric Cancer After R0 Surgical Resection: A Meta-Analysis of Randomized Trials. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s86. DOI: 10.1016/j.ijrobp.2013.06.223.
- Inhibition of Hsp27 Radiosensitizes Head-and-Neck Cancer by Modulating Deoxyribonucleic Acid RepairGuttmann DM, Hart L, Du K, Seletsky A, Koumenis C. Inhibition of Hsp27 Radiosensitizes Head-and-Neck Cancer by Modulating Deoxyribonucleic Acid Repair. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: 168-175. PMID: 23849696, DOI: 10.1016/j.ijrobp.2013.05.028.
- Preclinical Investigation of Hsp27 LNA as a Novel Radiosensitizer in Head-and-Neck CancerGuttmann D, Hart L, Du K, Koumenis C. Preclinical Investigation of Hsp27 LNA as a Novel Radiosensitizer in Head-and-Neck Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s691. DOI: 10.1016/j.ijrobp.2012.07.1846.
- Oxidative Stress and Photodynamic Therapy for Prostate CancerDu K, Finlay J, Zhu T, Busch T. Oxidative Stress and Photodynamic Therapy for Prostate Cancer. 2011, 277-300. DOI: 10.1007/978-1-61779-397-4_14.
- Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trialsDu KL, Bae K, Movsas B, Yan Y, Bryan C, Bruner DW. Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials. Supportive Care In Cancer 2011, 20: 1317-1325. PMID: 21720747, DOI: 10.1007/s00520-011-1219-4.
- Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesotheliomaDu KL, Both S, Friedberg JS, Rengan R, Hahn SM, Cengel KA. Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma. Cancer Biology & Therapy 2010, 10: 425-429. PMID: 20699634, DOI: 10.4161/cbt.10.5.12616.
- The Impact of Marital Status and Race in Patients Enrolled in Radiation Oncology Group (RTOG) Prostate Cancer TrialsDu K, Bae K, Movsas B, Gamerman V, Coyne J, Bryan C, Watkins-Bruner D. The Impact of Marital Status and Race in Patients Enrolled in Radiation Oncology Group (RTOG) Prostate Cancer Trials. International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s131. DOI: 10.1016/j.ijrobp.2009.07.313.
- Phase I Trial Utilizing Motexafin Lutetium Mediated PDT for Recurrent Prostate CancerDu K, Patel H, Mick R, Zhu T, Finlay J, Kao G, Malkowicz S, Busch T, Hahn S, Cengel K. Phase I Trial Utilizing Motexafin Lutetium Mediated PDT for Recurrent Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s306. DOI: 10.1016/j.ijrobp.2008.06.1069.
- Intensity Modulated Radiation Therapy for the Treatment of Malignant MesotheliomaDu K, Both S, Hahn S. Intensity Modulated Radiation Therapy for the Treatment of Malignant Mesothelioma. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s512. DOI: 10.1016/j.ijrobp.2007.07.1735.
- Patterns and Levels of Hypoxia in Head and Neck Squamous Cell Carcinomas and Their Relationship to Patient OutcomeEvans SM, Du KL, Chalian AA, Mick R, Zhang PJ, Hahn SM, Quon H, Lustig R, Weinstein GS, Koch CJ. Patterns and Levels of Hypoxia in Head and Neck Squamous Cell Carcinomas and Their Relationship to Patient Outcome. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: 1024-1031. PMID: 17967299, PMCID: PMC2737259, DOI: 10.1016/j.ijrobp.2007.04.067.
- Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancerDu KL, Mick R, Busch TM, Zhu TC, Finlay JC, Yu G, Yodh AG, Malkowicz SB, Smith D, Whittington R, Stripp D, Hahn SM. Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer. Lasers In Surgery And Medicine 2006, 38: 427-434. PMID: 16788929, DOI: 10.1002/lsm.20341.
- The Prognostic Role of Hypoxia in Head and Neck Squamous Cell Tumors, as Measured by EF5, is Influenced by EF5 Binding PatternsDu K, Chalian A, Zhang P, Hahn S, Quon H, Weinstein G, Koch C, Evans S. The Prognostic Role of Hypoxia in Head and Neck Squamous Cell Tumors, as Measured by EF5, is Influenced by EF5 Binding Patterns. International Journal Of Radiation Oncology • Biology • Physics 2005, 63: s478-s479. DOI: 10.1016/j.ijrobp.2005.07.814.
- Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular developmentLi J, Zhu X, Chen M, Cheng L, Zhou D, Lu MM, Du K, Epstein JA, Parmacek MS. Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proceedings Of The National Academy Of Sciences Of The United States Of America 2005, 102: 8916-8921. PMID: 15951419, PMCID: PMC1157054, DOI: 10.1073/pnas.0503741102.
- Megakaryoblastic Leukemia Factor-1 Transduces Cytoskeletal Signals and Induces Smooth Muscle Cell Differentiation from Undifferentiated Embryonic Stem Cells*Du KL, Chen M, Li J, Lepore JJ, Mericko P, Parmacek MS. Megakaryoblastic Leukemia Factor-1 Transduces Cytoskeletal Signals and Induces Smooth Muscle Cell Differentiation from Undifferentiated Embryonic Stem Cells*. Journal Of Biological Chemistry 2004, 279: 17578-17586. PMID: 14970199, DOI: 10.1074/jbc.m400961200.
- Myocardin Is a Critical Serum Response Factor Cofactor in the Transcriptional Program Regulating Smooth Muscle Cell DifferentiationDu KL, Ip HS, Li J, Chen M, Dandre F, Yu W, Lu MM, Owens GK, Parmacek MS. Myocardin Is a Critical Serum Response Factor Cofactor in the Transcriptional Program Regulating Smooth Muscle Cell Differentiation. Molecular And Cellular Biology 2003, 23: 2425-2437. PMID: 12640126, PMCID: PMC150745, DOI: 10.1128/mcb.23.7.2425-2437.2003.
- SM22β encodes a lineage-restricted cytoskeletal protein with a unique developmentally regulated pattern of expressionZhang JC, Helmke BP, Shum A, Du K, Yu WW, Lu MM, Davies PF, Parmacek MS. SM22β encodes a lineage-restricted cytoskeletal protein with a unique developmentally regulated pattern of expression. Cells And Development 2002, 115: 161-166. PMID: 12049783, DOI: 10.1016/s0925-4773(02)00088-6.
- Binding of Serum Response Factor to CArG Box Sequences Is Necessary but Not Sufficient to Restrict Gene Expression to Arterial Smooth Muscle Cells*Strobeck M, Kim S, Zhang J, Clendenin C, Du K, Parmacek M. Binding of Serum Response Factor to CArG Box Sequences Is Necessary but Not Sufficient to Restrict Gene Expression to Arterial Smooth Muscle Cells*. Journal Of Biological Chemistry 2001, 276: 16418-16424. PMID: 11279108, DOI: 10.1074/jbc.m100631200.
- Analysis of SM22α-Deficient Mice Reveals Unanticipated Insights into Smooth Muscle Cell Differentiation and FunctionZhang J, Kim S, Helmke B, Yu W, Du K, Lu M, Strobeck M, Yu Q, Parmacek M. Analysis of SM22α-Deficient Mice Reveals Unanticipated Insights into Smooth Muscle Cell Differentiation and Function. Molecular And Cellular Biology 2001, 21: 1336-1344. PMID: 11158319, PMCID: PMC99586, DOI: 10.1128/mcb.2001.21.4.1336-1344.2001.